A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Public ClinicalTrials.gov record NCT02279719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase Ib/II Clinical Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Study identification
- NCT ID
- NCT02279719
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Interventions
- BBI503 Drug
- BBI608 Drug
- Sorafenib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Jun 30, 2019
- Completion
- Sep 30, 2019
- Last update posted
- Nov 14, 2023
2014 – 2019
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Mayo Clinic | Phoenix | Arizona | 85054 | — |
| Southern California Research Center | Coronado | California | 92118 | — |
| California Center Associates for Research and Excellence, Inc. (Ccare) | Encinitas | California | 92024 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| USOR - Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Baptist Health Medical Group Oncology, LLC | Miami | Florida | 33176 | — |
| Piedmont Cancer Institute, P.C. | Atlanta | Georgia | 30318 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Kansas City Research Institure | Kansas City | Missouri | 64131 | — |
| USOR - Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| The Valley Hospital Luckow Pavilion | Paramus | New Jersey | 07652 | — |
| USOR - New York Oncology Hematology | Albany | New York | 12206 | — |
| University of Rochester, Wilmot Cancer Institute | Rochester | New York | 14642 | — |
| Carolinas Health Care System | Charlotte | North Carolina | 28204 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati, Vontz Center | Cincinnati | Ohio | 45267 | — |
| Drexel University | Philadelphia | Pennsylvania | 19102 | — |
| USOR - Texas Oncology, Austin Midtown | Austin | Texas | 78705 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology - El Paso Cancer Treatment Center Joe Battle | El Paso | Texas | 79938 | — |
| USOR - Texas Oncology, Fort Worth 12th Ave | Fort Worth | Texas | 76104 | — |
| Oncology Consultants | Houston | Texas | 77030 | — |
| Texas Oncology-McAllen South Second Street | McAllen | Texas | 78503 | — |
| USOR - Texas Oncology, Tyler | Tyler | Texas | 75702 | — |
| Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2023 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02279719 live on ClinicalTrials.gov.